Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
June 30, 2026 3.445M
March 31, 2026 -10.64M
December 31, 2025 -3.057M
September 30, 2025 2.669M
June 30, 2025 -3.094M
March 31, 2025 -10.78M
December 31, 2024 0.217M
September 30, 2024 -2.323M
June 30, 2024 -2.562M
March 31, 2024 -9.126M
December 31, 2023 8.243M
September 30, 2023 -2.91M
June 30, 2023 -10.48M
March 31, 2023 -10.14M
December 31, 2022 -6.14M
September 30, 2022 -7.561M
June 30, 2022 -13.10M
March 31, 2022 -9.661M
December 31, 2021 -7.111M
September 30, 2021 -5.935M
June 30, 2021 -5.164M
March 31, 2021 -4.479M
December 31, 2020 -3.904M
Date Value
September 30, 2020 -2.341M
June 30, 2020 -4.909M
March 31, 2020 -3.385M
December 31, 2019 -3.953M
September 30, 2019 -1.668M
June 30, 2019 -2.18M
March 31, 2019 -2.313M
December 31, 2018 -1.94M
September 30, 2018 -2.084M
June 30, 2018 -1.994M
March 31, 2018 -3.482M
December 31, 2015 -3.543M
September 30, 2015 -3.142M
June 30, 2015 -3.238M
March 31, 2015 -2.784M
December 31, 2014 -2.486M
September 30, 2014 -2.567M
June 30, 2014 -3.127M
March 31, 2014 -3.242M
December 31, 2013 -2.389M
September 30, 2013 -1.453M
June 30, 2013 -1.391M
March 31, 2013 -1.804M

Free Cash Flow Definition

Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Myriad Genetics, Inc. -11.50M
BioRestorative Therapies, Inc. -3.808M
CareDx, Inc. 28.75M
Natera, Inc. -8.636M
Sera Prognostics, Inc. -6.363M